 Englewood Cliffs, NJ, April 22, 2021 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that its Board of Directors has unanimously voted to uplist to the NASDAQ. 